NASDAQ:RCEL
AVITA Medical, Inc. Stock News
$8.27
+0.350 (+4.42%)
At Close: May 17, 2024
AVITA Medical to Present at the Cowen 42nd Annual Health Care Conference
09:01pm, Wednesday, 23'rd Feb 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a te
AVITA Medical to Present at the Cowen 42nd Annual Health Care Conference
04:01pm, Wednesday, 23'rd Feb 2022
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use
09:01pm, Thursday, 17'th Feb 2022 GlobeNewswire Inc.
System enhanced in response to clinician workflow and usability feedback; new system simplifies process
AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results
09:01pm, Tuesday, 15'th Feb 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a te
AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results
04:01pm, Tuesday, 15'th Feb 2022
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Medical to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
09:01pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a te
RECELL® System Data to be Presented at 44th Annual John A. Boswick Burn & Wound Care Symposium
01:00pm, Monday, 24'th Jan 2022 GlobeNewswire Inc.
Data presentations highlight broad clinical adoption of the RECELL® System for treatment of burn wounds Data presentations highlight broad clinical adoption of the RECELL® System for treatment of bu
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Soft-Tissue Reconstruction
09:01pm, Thursday, 06'th Jan 2022 GlobeNewswire Inc.
Topline data expected in second half of 2022 Topline data expected in second half of 2022
AVITA Medical Is Interesting, But Not Just Yet
08:30am, Tuesday, 21'st Dec 2021
The company is impacted by staffing issues and the pandemic which hamper growth at the moment, but the shares are already at a 52-week low.
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation of Stable Vitiligo
09:01pm, Wednesday, 15'th Dec 2021 GlobeNewswire Inc.
Topline data expected in second half of 2022 Topline data expected in second half of 2022
AVITA Medical, Inc. Announces Adjournment of 2021 Annual Stockholder Meeting
12:02am, Wednesday, 15'th Dec 2021 GlobeNewswire Inc.
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a tec
AVITA Medical to Present at Upcoming Investor Conferences
04:01pm, Tuesday, 16'th Nov 2021
VALENCIA, Calif., and MELBOURNE, Australia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tec
AVITA Medical, Inc.'s (RCEL) CEO Mike Perry on Q1 2022 Results - Earnings Call Transcript
10:05pm, Monday, 08'th Nov 2021
AVITA Medical, Inc.'s (RCEL) CEO Mike Perry on Q1 2022 Results - Earnings Call Transcript
AVITA Medical, Inc. (RCEL) Soars 8%: Is Further Upside Left in the Stock?
08:24am, Friday, 05'th Nov 2021
AVITA Medical, Inc. (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
AVITA Medical to Announce Fiscal First Quarter 2022 Financial Results
04:01pm, Monday, 25'th Oct 2021
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
